Healthcare stocks rallied in 2025, breaking a two-year slump as investors chased steadier rates, better valuations, and ...

Discover the PEG ratio's role in evaluating stock potential by balancing earnings growth with stock prices, aiding in ...

BEIJING -- A global ranking of fast-growing startups in 2025 showed that companies headquartered in China accounted for over ...

The biotech sector is one that’s become red-hot, at least in recent years. After around a decade of stagnation, investors ...

US$4 billion in Hong Kong in the first three weeks of 2026, with hundreds more lining up to list, Bonnie Chan says.

Bristol Myers Squibb and Microsoft 's new partnership aimed at accelerating early detection of lung cancer marks the latest ...

The words “sure-fire” and biotechnology stocks rarely go together. This is a sector of the stock market that carries ...

The company made an even more dramatic claim the following month, when it announced it had created three dire wolves. These ...

The green shoots suggesting a comeback was in sight for biotech stocks last year have mostly grown into proverbial flowering plants—but one company’s precipitous year-over-year decline in market ...

Oncolytics Biotech Inc. (NASDAQ:ONCY) shared a leadership update on January 7, 2026. With the appointment of Dr. Eileen ...

FBT returned 29% over the past year and gained 5.4% in the first week of 2026. Federal Reserve officials forecast another 150 basis points of rate cuts in 2026. Healthcare stocks trade at some of the ...

Reflecting the moving tide from New York to Hong Kong, EV maker Zeekr delisted from the New York Stock Exchange in December, just a year and a half after raising $440 million in its 2024 IPO, as it ...